The legacy status of Viagra, and the parent firm copyright, presents a challenging question for investors . While profits initially exploded , the approaching patent expiry and rising generic competition https://zubairwqys188535.bloggadores.com/40303790/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment